$135 Million is the total value of Virtus ETF Advisers LLC's 147 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 17.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ETP | Buy | ENERGY TRANSFER PRTNRS L Punit ltd partn | $9,945,000 | +141.3% | 261,222 | +104.9% | 7.38% | +30.0% |
| WPZ | Buy | WILLIAMS PARTNERS L P NEW | $8,188,000 | +185.3% | 236,361 | +68.4% | 6.08% | +53.7% |
| SXL | Buy | SUNOCO LOGISTICS PRTNRS L P | $6,699,000 | +101.5% | 232,999 | +75.7% | 4.97% | +8.5% |
| BPL | Buy | BUCKEYE PARTNERS L Punit ltd partn | $6,013,000 | +66.5% | 85,491 | +60.9% | 4.46% | -10.3% |
| MPLX | Buy | MPLX LP | $5,723,000 | +99.1% | 170,189 | +75.8% | 4.25% | +7.2% |
| EEP | Buy | ENBRIDGE ENERGY PARTNERS L P | $5,364,000 | +244.1% | 231,210 | +171.7% | 3.98% | +85.3% |
| WMB | Buy | WILLIAMS COS INC DEL | $4,915,000 | +127.5% | 227,215 | +69.0% | 3.65% | +22.6% |
| MMP | Buy | MAGELLAN MIDSTREAM PRTNRS LP | $4,562,000 | +64.0% | 60,029 | +48.5% | 3.39% | -11.6% |
| ET | Buy | ENERGY TRANSFER EQUITY L P | $4,477,000 | +404.2% | 311,573 | +150.2% | 3.32% | +171.7% |
| EPD | Buy | ENTERPRISE PRODS PARTNERS L | $4,460,000 | +55.3% | 152,424 | +30.7% | 3.31% | -16.3% |
| OKS | Buy | ONEOK PARTNERS LPunit ltd partn | $4,134,000 | +324.9% | 103,206 | +233.0% | 3.07% | +128.8% |
| PAA | Buy | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $3,878,000 | +711.3% | 141,065 | +518.5% | 2.88% | +336.7% |
| TLLP | Buy | TESORO LOGISTICS LP | $3,802,000 | +216.3% | 76,763 | +191.5% | 2.82% | +70.4% |
| ENLK | Buy | ENLINK MIDSTREAM PARTNERS LP | $3,371,000 | +424.3% | 202,717 | +280.7% | 2.50% | +182.4% |
| EQM | Buy | EQT MIDSTREAM PARTNERS LPunit ltd partn | $3,313,000 | +107.6% | 41,252 | +92.4% | 2.46% | +11.8% |
| WES | Buy | WESTERN GAS PARTNERS LP | $2,548,000 | +96.5% | 50,552 | +69.2% | 1.89% | +5.8% |
| GEL | Buy | GENESIS ENERGY L Punit ltd partn | $2,398,000 | +64.4% | 62,485 | +36.1% | 1.78% | -11.4% |
| CEQP | Buy | CRESTWOOD EQUITY PARTNERS LPunit ltd partner | $2,343,000 | +391.2% | 116,237 | +184.1% | 1.74% | +164.7% |
| PSXP | Buy | PHILLIPS 66 PARTNERS LP | $1,992,000 | +71.6% | 35,654 | +92.3% | 1.48% | -7.6% |
| NGL | Buy | NGL ENERGY PARTNERS LP | $1,496,000 | +393.7% | 77,428 | +92.3% | 1.11% | +166.2% |
| DCP | Buy | DCP MIDSTREAM PARTNERS LP | $1,341,000 | +72.4% | 38,886 | +36.1% | 1.00% | -7.2% |
| TSRO | Buy | TESARO INC | $1,108,000 | +413.0% | 13,178 | +168.7% | 0.82% | +175.8% |
| TRGP | Sell | TARGA RES CORP | $1,077,000 | -10.2% | 25,563 | -36.3% | 0.80% | -51.6% |
| TCP | Buy | TC PIPELINES LP | $889,000 | +128.5% | 15,519 | +92.4% | 0.66% | +23.1% |
| SHLX | Buy | SHELL MIDSTREAM PARTNERS L Punit ltd int | $859,000 | +1520.8% | 25,425 | +1659.5% | 0.64% | +774.0% |
| WGP | Buy | WESTERN GAS EQUITY PARTNERS | $788,000 | +44.3% | 20,602 | +34.6% | 0.58% | -22.2% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $613,000 | -3.8% | 92,536 | -32.2% | 0.46% | -48.2% |
| SE | Buy | SPECTRA ENERGY CORP | $597,000 | +129.6% | 16,311 | +92.3% | 0.44% | +23.7% |
| RTRX | Buy | RETROPHIN INC | $585,000 | +49.6% | 32,857 | +14.7% | 0.43% | -19.5% |
| EXEL | Sell | EXELIXIS INC | $580,000 | +26.6% | 74,230 | -35.1% | 0.43% | -31.9% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $567,000 | +34.0% | 24,345 | +133.0% | 0.42% | -27.8% |
| SGEN | Sell | SEATTLE GENETICS INC | $565,000 | +10.8% | 13,991 | -3.8% | 0.42% | -40.4% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $563,000 | +0.5% | 50,287 | -25.0% | 0.42% | -45.9% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $561,000 | -5.6% | 4,705 | -15.1% | 0.42% | -49.1% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $552,000 | -22.1% | 24,323 | -35.5% | 0.41% | -58.0% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $553,000 | -6.0% | 42,277 | -21.4% | 0.41% | -49.4% |
| PDLI | Buy | PDL BIOPHARMA INC | $546,000 | +3.4% | 173,837 | +9.6% | 0.40% | -44.3% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $546,000 | +177.2% | 3,826 | +149.3% | 0.40% | +49.4% |
| MDVN | Sell | MEDIVATION INC | $546,000 | -16.4% | 9,058 | -36.2% | 0.40% | -55.0% |
| BIIB | Buy | BIOGEN INC | $544,000 | +2.3% | 2,251 | +10.1% | 0.40% | -44.9% |
| INCY | Buy | INCYTE CORP | $545,000 | +46.9% | 6,820 | +33.4% | 0.40% | -20.9% |
| GILD | Buy | GILEAD SCIENCES INC | $543,000 | +1.7% | 6,511 | +12.1% | 0.40% | -45.2% |
| AMGN | Sell | AMGEN INC | $541,000 | -0.9% | 3,557 | -2.4% | 0.40% | -46.5% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $539,000 | +32.1% | 21,130 | +37.1% | 0.40% | -28.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $537,000 | +31.3% | 5,073 | +38.3% | 0.40% | -29.1% |
| RPTP | Sell | RAPTOR PHARMACEUTICAL CORP | $535,000 | -8.4% | 99,654 | -21.5% | 0.40% | -50.7% |
| CELG | Buy | CELGENE CORP | $531,000 | +8.6% | 5,386 | +10.3% | 0.39% | -41.5% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $529,000 | +52.0% | 61,274 | +67.0% | 0.39% | -18.0% |
| ENLC | Buy | ENLINK MIDSTREAM LLC | $528,000 | +172.2% | 33,190 | +92.4% | 0.39% | +46.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $522,000 | +7.2% | 6,713 | +13.7% | 0.39% | -42.3% |
| RLYP | Buy | RELYPSA INC | $521,000 | +316.8% | 28,163 | +205.2% | 0.39% | +125.0% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $520,000 | +51.2% | 48,151 | +29.2% | 0.39% | -18.6% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $519,000 | +36.2% | 1,485 | +40.5% | 0.38% | -26.7% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $514,000 | -6.4% | 23,292 | +24.6% | 0.38% | -49.6% |
| OMER | Buy | OMEROS CORP | $514,000 | -24.3% | 48,887 | +10.5% | 0.38% | -59.3% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $514,000 | -2.3% | 36,153 | -5.5% | 0.38% | -47.4% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $512,000 | +28.0% | 5,955 | +18.3% | 0.38% | -31.0% |
| MDCO | Sell | MEDICINES CO | $502,000 | +3.1% | 14,919 | -2.7% | 0.37% | -44.4% |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $499,000 | +10.2% | 118,285 | +13.9% | 0.37% | -40.7% |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $489,000 | -17.4% | 66,113 | -28.6% | 0.36% | -55.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $484,000 | +9.8% | 4,147 | +30.9% | 0.36% | -41.0% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $475,000 | -25.4% | 277,607 | -14.1% | 0.35% | -59.8% |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $472,000 | +78.8% | 87,477 | +177.0% | 0.35% | -3.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $450,000 | +118.4% | 13,877 | +88.6% | 0.33% | +17.6% |
| CQP | New | CHENIERE ENERGY PARTNERS LP | $350,000 | – | 11,685 | +100.0% | 0.26% | – |
| XNCR | Sell | XENCOR INC | $335,000 | +38.4% | 17,649 | -2.2% | 0.25% | -25.2% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $285,000 | +30.7% | 12,651 | +10.7% | 0.21% | -29.3% |
| CYTK | Buy | CYTOKINETICS INC | $279,000 | +78.8% | 29,379 | +32.8% | 0.21% | -3.7% |
| NLNK | Buy | NEWLINK GENETICS CORP | $275,000 | +114.8% | 24,463 | +248.0% | 0.20% | +15.9% |
| NVAX | Buy | NOVAVAX INC | $273,000 | +71.7% | 37,550 | +22.0% | 0.20% | -7.3% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $270,000 | +74.2% | 5,281 | +0.6% | 0.20% | -6.5% |
| BLUE | Buy | BLUEBIRD BIO INC | $267,000 | +47.5% | 6,165 | +45.0% | 0.20% | -20.5% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $267,000 | +36.2% | 75,100 | +13.1% | 0.20% | -26.7% |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $265,000 | +61.6% | 32,726 | +1.2% | 0.20% | -12.8% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $264,000 | +78.4% | 8,774 | +90.7% | 0.20% | -3.9% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $264,000 | +39.7% | 13,046 | +24.4% | 0.20% | -24.6% |
| VTAE | Buy | VITAE PHARMACEUTICALS INC | $264,000 | +127.6% | 24,463 | +39.5% | 0.20% | +22.5% |
| BLCM | Buy | BELLICUM PHARMACEUTICALS INC | $263,000 | +97.7% | 20,302 | +43.0% | 0.20% | +6.6% |
| MGNX | Buy | MACROGENICS INC | $263,000 | +67.5% | 9,762 | +16.4% | 0.20% | -9.7% |
| NERV | New | MINERVA NEUROSCIENCES INC | $262,000 | – | 25,630 | +100.0% | 0.19% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $261,000 | +301.5% | 59,537 | +245.2% | 0.19% | +115.6% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $259,000 | +115.8% | 68,254 | +57.5% | 0.19% | +16.4% |
| RDUS | Buy | RADIUS HEALTH INC | $257,000 | +100.8% | 6,986 | +71.0% | 0.19% | +8.5% |
| AGEN | Sell | AGENUS INC | $256,000 | -4.5% | 63,191 | -2.1% | 0.19% | -48.5% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $253,000 | +10.0% | 17,649 | -8.4% | 0.19% | -40.7% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $252,000 | +34.0% | 17,302 | +77.1% | 0.19% | -27.8% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $250,000 | +100.0% | 20,269 | +63.9% | 0.19% | +8.1% |
| ADXS | Sell | ADVAXIS INC | $250,000 | -11.7% | 30,885 | -1.4% | 0.19% | -52.3% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $250,000 | – | 6,443 | +100.0% | 0.19% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $249,000 | – | 8,344 | +100.0% | 0.18% | – |
| GERN | Buy | GERON CORP | $246,000 | +50.9% | 91,851 | +64.2% | 0.18% | -18.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $247,000 | +87.1% | 12,949 | +91.3% | 0.18% | +0.5% |
| PTCT | Buy | PTC THERAPEUTICS INC | $245,000 | +329.8% | 34,849 | +297.0% | 0.18% | +130.4% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $245,000 | +70.1% | 17,865 | +137.4% | 0.18% | -8.1% |
| AXGT | Buy | AXOVANT SCIENCES LTD | $245,000 | +70.1% | 19,065 | +51.6% | 0.18% | -8.1% |
| KITE | Buy | KITE PHARMA INC | $244,000 | +34.8% | 4,889 | +24.1% | 0.18% | -27.3% |
| FGEN | Buy | FIBROGEN INC | $244,000 | +39.4% | 14,866 | +81.0% | 0.18% | -24.9% |
| INSM | Buy | INSMED INC | $242,000 | +29.4% | 24,536 | +65.9% | 0.18% | -30.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $242,000 | +28.7% | 5,324 | +11.8% | 0.18% | -30.5% |
| TRVN | Buy | TREVENA INC | $242,000 | +22.2% | 38,367 | +59.9% | 0.18% | -34.1% |
| RXDX | Buy | IGNYTA INC | $242,000 | +68.1% | 44,599 | +109.2% | 0.18% | -9.1% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $241,000 | +225.7% | 84,907 | +223.5% | 0.18% | +75.5% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $241,000 | -6.2% | 5,837 | -7.7% | 0.18% | -49.4% |
| OPHT | Buy | OPHTHOTECH CORP | $240,000 | +62.2% | 4,702 | +34.0% | 0.18% | -12.7% |
| SGMO | Buy | SANGAMO BIOSCIENCES INC | $239,000 | +35.8% | 41,249 | +41.9% | 0.18% | -26.9% |
| ADRO | Buy | ADURO BIOTECH INC | $238,000 | +133.3% | 21,010 | +163.7% | 0.18% | +25.5% |
| LOXO | Buy | LOXO ONCOLOGY INC | $237,000 | -0.4% | 10,231 | +17.4% | 0.18% | -46.3% |
| NK | Buy | NANTKWEST INC | $236,000 | +96.7% | 37,895 | +160.2% | 0.18% | +6.1% |
| MCRB | Buy | SERES THERAPEUTICS INC | $235,000 | +34.3% | 8,098 | +23.1% | 0.17% | -27.8% |
| XLRN | Buy | ACCELERON PHARMA INC | $235,000 | +54.6% | 6,910 | +20.0% | 0.17% | -16.7% |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $235,000 | +35.8% | 20,939 | +65.3% | 0.17% | -26.9% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $230,000 | +115.0% | 9,735 | +86.1% | 0.17% | +16.3% |
| JUNO | Buy | JUNO THERAPEUTICS INC | $231,000 | +13.2% | 6,017 | +12.4% | 0.17% | -39.1% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $230,000 | – | 43,272 | +100.0% | 0.17% | – |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $229,000 | – | 16,223 | +100.0% | 0.17% | – |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $229,000 | +13.4% | 14,291 | +48.2% | 0.17% | -38.8% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $228,000 | +132.7% | 7,666 | +130.8% | 0.17% | +25.2% |
| SRNE | Buy | SORRENTO THERAPEUTICS INC | $226,000 | +16.5% | 40,438 | +11.9% | 0.17% | -37.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $226,000 | +28.4% | 4,078 | +45.7% | 0.17% | -30.6% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $222,000 | -4.3% | 40,705 | +48.5% | 0.16% | -48.4% |
| EPZM | Buy | EPIZYME INC | $223,000 | +12.1% | 21,750 | +32.6% | 0.16% | -39.8% |
| INO | Sell | INOVIO PHARMACEUTICALS INC | $222,000 | -37.1% | 24,058 | -40.6% | 0.16% | -66.0% |
| AVXS | New | AVEXIS INC | $223,000 | – | 5,869 | +100.0% | 0.16% | – |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $221,000 | +14.5% | 29,590 | +38.1% | 0.16% | -38.3% |
| ZIOP | Buy | ZIOPHARM ONCOLOGY INC | $221,000 | +2.8% | 40,175 | +38.4% | 0.16% | -44.6% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $220,000 | -3.9% | 26,974 | -4.3% | 0.16% | -48.3% |
| CEMP | Buy | CEMPRA INC | $219,000 | +55.3% | 13,284 | +64.9% | 0.16% | -16.0% |
| IMGN | Buy | IMMUNOGEN INC | $218,000 | +32.9% | 70,796 | +267.6% | 0.16% | -28.3% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $214,000 | +20.2% | 8,582 | +18.0% | 0.16% | -35.1% |
| TGTX | Buy | TG THERAPEUTICS INC | $214,000 | +4.9% | 35,297 | +47.2% | 0.16% | -43.4% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $211,000 | +14.1% | 19,501 | +42.7% | 0.16% | -38.4% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $212,000 | +5.5% | 5,068 | +2.3% | 0.16% | -43.3% |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $210,000 | +6.1% | 26,915 | +4.7% | 0.16% | -42.9% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $205,000 | +28.1% | 30,617 | +70.8% | 0.15% | -30.9% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $198,000 | +30.3% | 4,050 | +68.5% | 0.15% | -29.7% |
| QURE | Buy | UNIQURE NV | $195,000 | +16.1% | 26,511 | +86.9% | 0.14% | -37.2% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $194,000 | +61.7% | 11,710 | +54.4% | 0.14% | -12.7% |
| PRTA | Buy | PROTHENA CORP PLC | $193,000 | +28.7% | 5,509 | +50.9% | 0.14% | -30.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $188,000 | -13.8% | 81,010 | -7.0% | 0.14% | -53.3% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $154,000 | -17.2% | 15,540 | +41.1% | 0.11% | -55.5% |
| NS | Buy | NUSTAR ENERGY LP | $152,000 | +137.5% | 3,057 | +92.5% | 0.11% | +28.4% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $134,000 | -36.8% | 46,269 | +51.6% | 0.10% | -66.1% |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $132,000 | +88.6% | 2,788 | +92.4% | 0.10% | +2.1% |
| OKE | New | ONEOK INC NEW | $113,000 | – | 2,378 | +100.0% | 0.08% | – |
| USO | Sell | UNITED STATES OIL FUND LPunits | $16,000 | -91.8% | 1,426 | -92.9% | 0.01% | -95.5% |
| New | STATE STR CORP | $9,000 | – | 150 | +100.0% | 0.01% | – | |
| New | STATE STR CORP | $2,000 | – | 300 | +100.0% | 0.00% | – | |
| CMRX | Exit | CHIMERIX INC | $0 | – | -7,232 | -100.0% | -0.05% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -12,922 | -100.0% | -0.14% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -16,267 | -100.0% | -0.14% | – |
| NWBO | Exit | NORTHWEST BIOTHERAPEUTICS IN | $0 | – | -78,696 | -100.0% | -0.16% | – |
| DNAI | Exit | PRONAI THERAPEUTICS INC | $0 | – | -17,902 | -100.0% | -0.17% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -26,478 | -100.0% | -0.17% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -74,038 | -100.0% | -0.20% | – |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -116,667 | -100.0% | -0.20% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -7,828 | -100.0% | -0.23% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -21,910 | -100.0% | -0.24% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -34,021 | -100.0% | -0.25% | – |
| ARWR | Exit | ARROWHEAD RESH CORP | $0 | – | -44,714 | -100.0% | -0.30% | – |
| ABUS | Exit | ARBUTUS BIOPHARMA CORP | $0 | – | -54,471 | -100.0% | -0.31% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -14,884 | -100.0% | -0.31% | – |
| ANAC | Exit | ANACOR PHARMACEUTICALS INC | $0 | – | -5,147 | -100.0% | -0.38% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -101,554 | -100.0% | -0.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.